Cipher Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA17253X1050
CAD
16.70
-0.15 (-0.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
70.49
45.71
28.56
26.92
27.51
28.98
29.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
70.49
45.71
28.56
26.92
27.51
28.98
29.79
Raw Material Cost
24.12
18.19
7.15
6.48
5.28
5.34
4.99
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
11.53
7.50
3.50
2.48
1.99
1.37
5.72
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.63
0.00
0.00
0.01
0.12
0.43
1.28
Selling and Distribution Expenses
23.27
20.49
7.69
5.92
5.74
6.36
8.23
Other Expenses
-1.31
-0.75
-0.33
-0.24
-0.20
-0.16
-0.65
Total Expenditure (Excl Depreciation)
47.42
38.67
15.02
12.53
11.14
11.88
13.75
Operating Profit (PBDIT) excl Other Income
23.1
7
13.5
14.399999999999999
16.4
17.1
16
Other Income
2.54
-2.98
3.57
0.57
0.12
0.16
0.09
Operating Profit (PBDIT)
35.71
9.55
18.77
16.24
17.37
18.88
17.71
Interest
1.63
0.00
0.00
0.01
0.12
0.43
1.28
Exceptional Items
0.00
0.00
0.00
0.00
-2.51
-8.07
-7.28
Gross Profit (PBDT)
46.38
27.52
21.41
20.43
22.23
23.64
24.80
Depreciation
10.11
5.50
1.66
1.29
0.88
1.62
1.58
Profit Before Tax
23.98
4.05
17.12
14.94
13.87
8.77
7.58
Tax
-14.20
-11.77
-10.40
-19.73
4.14
2.88
4.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
38.19
15.82
27.51
34.68
9.73
5.88
3.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
38.19
15.82
27.51
34.68
9.73
5.88
3.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
38.19
15.82
27.51
34.68
9.73
5.88
3.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
173.05
147.19
106.17
86.83
49.13
41.59
36.32
Earnings per share (EPS)
1.47
0.63
1.08
1.34
0.36
0.22
0.16
Diluted Earnings per share
1.47
0.63
1.08
1.34
0.36
0.22
0.16
Operating Profit Margin (Excl OI)
32.73%
15.39%
47.41%
53.45%
59.51%
59.02%
53.86%
Gross Profit Margin
48.35%
20.9%
65.72%
60.3%
53.59%
35.83%
30.72%
PAT Margin
54.17%
34.6%
96.32%
128.83%
35.36%
20.3%
11.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 54.27% vs 59.79% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 141.77% vs -42.55% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 165.60% vs -17.76% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Cipher Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
70.49
628.43
-557.94
-88.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
70.49
628.43
-557.94
-88.78%
Raw Material Cost
24.12
431.98
-407.86
-94.42%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
11.53
109.22
-97.69
-89.44%
Power Cost
0
0
0.00
Manufacturing Expenses
1.63
56.78
-55.15
-97.13%
Selling and Distribution Expenses
23.27
223.92
-200.65
-89.61%
Other Expenses
-1.31
-16.60
15.29
92.11%
Total Expenditure (Excl Depreciation)
47.42
655.90
-608.48
-92.77%
Operating Profit (PBDIT) excl Other Income
23.07
-27.47
50.54
183.98%
Other Income
2.54
44.35
-41.81
-94.27%
Operating Profit (PBDIT)
35.71
83.98
-48.27
-57.48%
Interest
1.63
56.78
-55.15
-97.13%
Exceptional Items
0.00
-44.79
44.79
100.00%
Gross Profit (PBDT)
46.38
196.45
-150.07
-76.39%
Depreciation
10.11
67.10
-56.99
-84.93%
Profit Before Tax
23.98
-84.69
108.67
128.32%
Tax
-14.20
59.33
-73.53
-123.93%
Provisions and contingencies
0
0
0.00
Profit After Tax
38.19
-145.06
183.25
126.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
38.19
-145.06
183.25
126.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
1.04
-1.04
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
38.19
-144.02
182.21
126.52%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
173.05
-41.27
214.32
519.31%
Earnings per share (EPS)
1.47
-0.31
1.78
574.19%
Diluted Earnings per share
1.47
-0.31
1.78
574.19%
Operating Profit Margin (Excl OI)
32.73%
-4.37%
0.00
37.10%
Gross Profit Margin
48.35%
-2.80%
0.00
51.15%
PAT Margin
54.17%
-23.08%
0.00
77.25%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 7.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 54.27% vs 59.79% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3.82 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 141.77% vs -42.55% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.32 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 165.60% vs -17.76% in Dec 2024

Annual - Interest
Interest 0.16 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.73%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024